|
Volumn 162, Issue 22, 2000, Pages 3184-3188
|
Should all younger patients with breast cancer be offered adjuvant cytotoxic chemotherapy?;Bør alle yngre mammacancerpatienter tilbydes adjuverende cytotoksisk kemoterapi?
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ADJUVANT CHEMOTHERAPY;
ADULT;
AGE;
AGED;
ARTICLE;
BREAST TUMOR;
COMPARATIVE STUDY;
DENMARK;
FEMALE;
HUMAN;
MIDDLE AGED;
MORTALITY;
PROGNOSIS;
PROSPECTIVE STUDY;
RISK FACTOR;
ADULT;
AGE FACTORS;
AGED;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
DENMARK;
FEMALE;
HUMANS;
MIDDLE AGED;
PROGNOSIS;
PROSPECTIVE STUDIES;
RISK FACTORS;
|
EID: 0034729012
PISSN: 00415782
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|